Synthesis and characterization of hydroquinone fructoside using Leuconostoc mesenteroides levansucrase

  • Jin Kang
  • Young-Min Kim
  • Nahyun Kim
  • Du-Woon Kim
  • Seung-Hee Nam
  • Doman Kim
Biotechnological Products and Process Engineering


Hydroquinone (HQ) functions as a skin-whitening agent, but it has the potential to cause dermatitis. We synthesized a HQ fructoside (HQ-Fru) as a potential skin-whitening agent by reacting levansucrase from Leuconostoc mesenteroides with HQ as an acceptor and sucrose as a fructofuranose donor. The product was purified using 1-butanol partition and silica-gel column chromatography. The structure of the purified HQ-Fru was determined by 1H and 13C nuclear magnetic resonance, and the molecular ion of the product was observed at m/z 295 (C12 H16 O7 Na)+. The HQ-Fru was identified as 4-hydroxyphenyl-β-d-fructofuranoside. The optimum condition for HQ-Fru synthesis was determined using a response surface method (RSM), and the final optimum condition was 350 mM HQ, 115 mM sucrose, and 0.70 U/ml levansucrase, and the final HQ-Fru produced was 1.09 g/l. HQ-Fru showed anti-oxidation activities and inhibition against tyrosinase. The median inhibition concentration (IC50) of 1,1-diphenyl-2-picrylhydrazyl scavenging activity was 5.83 mM, showing higher antioxidant activity compared to β-arbutin (IC50 = 6.04 mM). The K i value of HQ-Fru (1.53 mM) against tyrosinase was smaller than that of β-arbutin (K i  = 2.8 mM), indicating that it was 1.8-times better as an inhibitor. The inhibition of lipid peroxidation by HQ-Fru was 105.3% that of HQ (100%) and 118.9 times higher than that of β-arbutin (0.89% of HQ).


Leuconostoc mesenteroides Levansucrase Hydroquinone Acceptor reaction Fructosylation 



This work was supported by 21C Frontier Microbial Genomics and the Applications Center Program. We thank the Korea Basic Science Institute Gwangju Branch for the NMR analysis.


  1. Belghith H, Song KB, Kim CH, Rhee SK (1996) Optimal conditions for levan formation by an overexpressed recombinant levansucrase. Biotechnol Lett 18:467–472CrossRefGoogle Scholar
  2. Borek C (2001) Antioxidant health effects of aged garlic extract. J Nutr 131:1010S–1015SGoogle Scholar
  3. Box GEP, Hunter WG, Hunter JS (1978) Statistics for experimenters. In: Box GEP, Hunter WG, Hunter JS (eds) An introduction to design, data analysis, and model building. Wiley, New YorkGoogle Scholar
  4. De Roos NM, Katan MB (1988) Effects of probiotic bacteria on diarrhea, lipid metabolism. Am J Clin Nutr 71:405–411Google Scholar
  5. Funayama M, Arakawa H, Yamamoto R, Nishino T, Shin T, Murao S (1995) Effects of alpha and beta arbutin on activity of tyrosinase from mushroom and mouse melanoma. Biosci Biotechnol Biochem 59:143–147CrossRefGoogle Scholar
  6. Hestrin S, Averini-Shapiro S, Ashner M (1943) The enzymatic production of levan. Biochem J 37:450–456Google Scholar
  7. Hijum SAFT, Bonting K, Maarel MJEC, Dijkhuizen L (2001) Purification of a novel fructosyltransferase from Lactobacillus reuteri strain 121 and characterization of the levan produced. FEMS Microbiol 205:323–328CrossRefGoogle Scholar
  8. Jin YH, Lee SJ, Chung MH, Park JH, Cho TH, Lee SK (1999) Aloesin and arbutin inhibit tyrosinase activity in a synergistic manner via a different action mechanism. Arch Pharm Res 22:232–236CrossRefGoogle Scholar
  9. Jun SY, Park KM, Choi KW, Jang MK, Kang HY, Lee SH, Park KH, Cha J (2008) Inhibitory effects of arbutin-beta-glycosides synthesized from enzymatic transglycosylation for melanogenesis. Biotechnol Lett 30:743–748CrossRefGoogle Scholar
  10. Kang HK, Seo MY, Seo ES, Kim D, Chung SY, Kimura A, Day DF, Robyt JF (2005) Cloning and expression of levansucrase from Leuconostoc mesenteroides B-512 FMC in Escherichia coli. Biochim Biophys Acta 1727:5–15Google Scholar
  11. Maeda K, Fukuda M (1991) Arbutin: mechanism of its depigmenting action in human melanocyte culture. Pharmacology 276:765–769Google Scholar
  12. Moon YH, Lee JH, Ahn JS, Nam SH, Oh DK, Park DH, Chung HJ, Kang SS, Day DF, Kim D (2006) Synthesis, structure analyses, and characterization of novel epigallocatechin gallate (EGCG) glycosides using the glucansucrase from Leuconostoc mesenteroides B-1299CB. J Agric Food Chem 54:1230–1237CrossRefGoogle Scholar
  13. Mukerjea R, Kim D, Robyt JF (1996) Simplified and improved methylation analysis of saccharides, using a modified procedure and thin-layer chromatography. Carbohydr Res 292:11–20Google Scholar
  14. Muller F (2000) The nature and mechanism of superoxide production by the electron transport chain: its relevance to aging. J Am Aging Assoc 23:227–253Google Scholar
  15. Nakano H, Hamayasu K, Nakagawa K, Tabata A, Fujita K, Hara K, Kiso T, Murakami H, Kitahata S (2002) Transglycosylation of hydroquinone and epicatechin by β-fructofuranosidase from Arthrobacter sp. J Appl Glycosci 49:115–121Google Scholar
  16. Nihei KI, Yamagiwa Y, Kamikawa T, Kubo I (2004) 2-Hydroxy-4-isopropyl benzaldehyde, a potent partial tyrosinase inhibitor. Bioorg Med Chem Lett 14:681–683CrossRefGoogle Scholar
  17. Parvez S, Kang M, Chun HS, Cho CW, Hong MC, Shin MK, Bae HS (2006) Survey and mechanism of skin depigmenting and lightening agents. Phytother Res 20:921–934CrossRefGoogle Scholar
  18. Pieroni A, Cassandra LQ, Villanelli ML, Mangino P, Sabbatini G, Santini L, Boccetti T, Profili M, Ciccioli T, Loredana GR, Antonini G, Girolamini C, Cecchi M, Tomasi M (2004) Ethnopharmacognostic survey on the natural ingredients used in folk cosmetics, cosmeceuticals and remedies for healing skin diseases in the inland Marches. J Ethnopharmacol 91:331–344CrossRefGoogle Scholar
  19. Riley PA (2003) Melanogenesis and Melanoma. Pigment Cell Res 16:548–552CrossRefGoogle Scholar
  20. Sreejayan N, Rao MNA (1997) Nitric oxide scavenging by curcuminoids. J Pharm Pharmacol 49:105–107Google Scholar
  21. Sreejayan N, Rao MNA, Priyadarsini KI, Devasagayam TPA (1997) Inhibition of radiation-induced lipid peroxidation by curcumin. Int J Pharm 151:127–130CrossRefGoogle Scholar
  22. Sugimoto K, Nishimura T, Nomura K, Sugimoto K, Takashi K (2003) Syntheses of arbutin-α-glycosides and a comparison of their inhibitory effects with those of α-arbutin and arbutin in human tyrosinase. Chem Pharm Bull 51:798–801CrossRefGoogle Scholar
  23. Sugimoto K, Nomura K, Nishimura T, Kiso T, Sugimoto K, Takashi K (2005) Syntheses of arbutin-α-glycosides and their inhibitory effects on human tyrosinase. J Biosci Bioeng 99:272–276CrossRefGoogle Scholar
  24. Tomita K, Fukudo M, Kawasaki K (1990) Mechanism of arbutin inhibitory effect on melanogenesis and effect on the human skin with cosmetic use. Fragrance J 6:72–77Google Scholar
  25. Yamamoto Y, Takashashi Y, Kawano M, Iizuka M, Matsumoto T, Saeki S, Yamaguchi H (2000) Hypercholesterolemic effects of levan in rat. In: Nishinari K (ed) Hydrocolloids (Part II),. Elsevier, New York, pp 399–400CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Jin Kang
    • 1
  • Young-Min Kim
    • 1
  • Nahyun Kim
    • 2
  • Du-Woon Kim
    • 3
  • Seung-Hee Nam
    • 4
  • Doman Kim
    • 1
  1. 1.School of Biological Sciences and TechnologyChonnam National UniversityGwangjuRepublic of Korea
  2. 2.Korean Minjok Leadership AcademyHoengseongRepublic of Korea
  3. 3.Eco Marine Bio-CenterJeonnamRepublic of Korea
  4. 4.Jeonnam Agricultural Research & Extension ServicesJeonnamRepublic of Korea

Personalised recommendations